0001209191-16-122631.txt : 20160523 0001209191-16-122631.hdr.sgml : 20160523 20160523163654 ACCESSION NUMBER: 0001209191-16-122631 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160519 FILED AS OF DATE: 20160523 DATE AS OF CHANGE: 20160523 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dimension Therapeutics, Inc. CENTRAL INDEX KEY: 0001592288 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 463942159 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 840 MEMORIAL DRIVE STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-401-0011 MAIL ADDRESS: STREET 1: 840 MEMORIAL DRIVE STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dybbs Michael CENTRAL INDEX KEY: 0001601264 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37601 FILM NUMBER: 161669500 MAIL ADDRESS: STREET 1: C/O NEW LEAF VENTURE PARTNERS STREET 2: 1200 PARK PLACE, SUITE 300 CITY: SAN MATEO STATE: CA ZIP: 94043 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-05-19 0 0001592288 Dimension Therapeutics, Inc. DMTX 0001601264 Dybbs Michael C/O DIMENSION THERAPEUTICS, INC. 840 MEMORIAL DRIVE, 4TH FLOOR CAMBRIDGE MA 02139 1 0 0 0 Stock Option (Right to Buy) 7.08 2016-05-19 4 A 0 32069 0.00 A 2026-05-18 Common Stock 32069 32069 D The options shall vest in full on the earlier of May 19, 2017 or the Issuer's next annual meeting of stockholders, subject to the director's continued service on the Board. /s/ Jean Franchi, as Attorney-in-Fact for Michael Dybbs 2016-05-23